Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

50
Top Analyst Upgrades and Downgrades: AEP, Facebook, Microsoft, PayPal, Philip Morris, Spotify, Under Armour and More

2018-07-20 247wallst
Stocks were indicated lower on Friday on more China woes, but it’s been a choppy time of late. The investing community has had less faith and has seen lower rewards from buying the dips in 2018 than in prior years. Many of those same investors also have been concerned about how they want their investments positioned ahead of the midterm elections, into international trade concerns and into 2019 and beyond.
WFCNP PM FB GLMD UAA MS.PRE WFC.PRL MS.PRF PYPL WFC.PRJ MS.PRG SKX MS.PRA WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO SPOT WFC.PRN AEP WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS AEP.PRA YUMC ISRG ETR UA SIX MS.PRI MS.PRK FDC RARX TRI MSFT ESRX

5
FDC vs. SPSC: Which Stock Is the Better Value Option?

2018-07-18 zacks
Investors interested in stocks from the Business - Services sector have probably already heard of First Data (FDC - Free Report) and SPS Commerce (SPSC - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
SPSC FDC

15
Here's Why You Should Add Avis Budget (CAR) to Your Portfolio

2018-07-09 zacks
A wise investment decision involves buying well-performing stocks at the right time while selling those that are at risk. A rise in share price and strong fundamentals signal a stock’s bullish run.
VEC ADPVV FDC ADP CAR

5
Mapping The Highest-Paid CEO In Every State

2018-07-09 valuewalkpremium
Have you ever wondered how much the highest-paid CEO in your state makes for a living? It turns out that climbing to the top of the corporate ladder can mean dramatically different things in different parts of the country. Our new map breaks down the highest-paid CEOs in each state, letting you easily see total compensation figures and the companies they work for.
FIBK FDC CSX

16
Here's Why Investors Should Retain Fang Holdings (SFUN) Stock

2018-07-06 zacks
A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions.
VEC FDC SFUN CAR

11
First Data Rides on Strategic Business Moves, Product Suite

2018-07-05 zacks
First Data Corporation (FDC - Free Report) stock has rallied 23.4% in the past six months against the industry’s loss of 0.1%.
VEC FDC CAR FLT

11
Superinvestor John Rogers Of Ariel Investments Lauds KKR's Looming PE Stock Shakeup

2018-07-02 forbes
Coming in July, the private equity world is in for a big change that could reshape the contours of the industry a decade after most blue chip firms began to join public stock markets.
FDC

12
i3 Verticals: Not Worth The Risk

2018-06-23 seekingalpha
i3 Verticals, a payment processing company, finalized its IPO at $13 per share and raised $86.5 million.
IIIV FDC

38
Oracle Corporation (ORCL) CEO Safra Catz and Mark Hurd on Q4 2018 Results - Earnings Call Transcript

2018-06-20 seekingalpha
Now, I'd like to turn the call over to Ken Bond, Senior Vice President. Sir, you may begin.
GD NBL TM TYT ZBRA N TOYOF RI OCLCF FDC SCHL 7203 6302 TIME ORCL

38
First Data Partners Mastercard for Digital Disbursements

2018-06-14 zacks
First Data Corporation (FDC - Free Report) has sealed a partnership deal with Mastercard Inc. (MA - Free Report) for making its Disburse-to-Debit solution available to Mastercard customers.
FDC MA WEX FLT YY

81
Proceed With Caution With Square Inc Stock

2018-06-14 investorplace
Square Inc (NYSE:SQ), the payment play from Twitter Inc (NYSE:TWTR) founder Jack Dorsey, has gained 400% in just 2.5 years on the New York Stock Exchange. It’s now worth $25 billion. This year alone, shares have almost tripled, rising from $23 to $63.
WFC WFCNP WFC.WS SQ SQNXF WFC.PRL DTK PYPL WFC.PRJ WFC.PRT INTU WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TWTR FDC WFC.PRY WFC.PRX WFC.PRW WFC.PRV

11
First Look At i3 Verticals' $80 Million IPO

2018-06-13 seekingalpha
i3 Verticals, a small-cap payment processing and software company, has filed for an $80 million IPO.
FDC

39
Wells Fargo simplifies payments pricing to compete with Square

2018-06-12 sfgate
Wells Fargo & Co. will simplify the prices it charges small businesses to accept credit and debit card transactions as the bank responds to pressure from startups such as Jack Dorsey’s Square.
WFC WFCNP WFC.WS WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN FDC WFC.PRY WFC.PRX WFC.PRW WFC.PRV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to FDC / First Data Corporation on message board site Silicon Investor.

FDC : First Data Corp HFDC HomeFed Corp. (OTC:BB)
Factual Data (FDCC) CSCO MSPG FDC JVLN Net Articles, Reader Highlight TD
MSFDC - Microsoft/First Data Corp Joint Venture
CUSIP: 32008D106